Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $458000.0.

  • Arcadia Biosciences' Change in Accured Expenses rose 52803.74% to $458000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $244000.0, marking a year-over-year increase of 12592.99%. This contributed to the annual value of -$303000.0 for FY2024, which is 4195.4% up from last year.
  • According to the latest figures from Q3 2025, Arcadia Biosciences' Change in Accured Expenses is $458000.0, which was up 52803.74% from -$417000.0 recorded in Q2 2025.
  • Arcadia Biosciences' 5-year Change in Accured Expenses high stood at $1.7 million for Q2 2021, and its period low was -$1.3 million during Q4 2021.
  • Its 5-year average for Change in Accured Expenses is -$118111.1, with a median of -$150000.0 in 2023.
  • Over the last 5 years, Arcadia Biosciences' Change in Accured Expenses had its largest YoY gain of 52803.74% in 2025, and its largest YoY loss of 73181.82% in 2025.
  • Over the past 5 years, Arcadia Biosciences' Change in Accured Expenses (Quarter) stood at -$1.3 million in 2021, then soared by 109.9% to $133000.0 in 2022, then plummeted by 266.92% to -$222000.0 in 2023, then soared by 287.39% to $416000.0 in 2024, then increased by 10.1% to $458000.0 in 2025.
  • Its Change in Accured Expenses was $458000.0 in Q3 2025, compared to -$417000.0 in Q2 2025 and -$213000.0 in Q1 2025.